FDA Law

MARCH 7, 2024

Tobolowsky & Véronique Li, Senior Medical Device Regulation Expert & David B. Moreover, DMCs are being used in trials of modest size and in the context of increased globalization of medical product development. DMC charters have also grown longer and more detailed. They also both stressed the value of previous DMC experience.

Clinic 105

Clinic Provider IT Utilities 105

Today's Hospitalist

APRIL 24, 2025

Key takeaways: Admission delays from the ED can adversely affect mortality, length of stay, medical errors and quality of care. Such delays can compromise patient care by increasing mortality, medical errors and length of stay. ” Nathan Baskin, MD San Francisco VA Medical Center And they succeeded. reduction. .”

Hospital 52

Hospital Patient-Centered Patients Education 52

FDA Law

FEBRUARY 4, 2024

Mullen — On January 18, 2024, the director of FDA’s Center for Devices and Radiological Health and the chief medical officer and acting director of CMS’ Center for Clinical Standards and Quality issued a joint press release supporting FDA’s recent proposed rule regulating Laboratory Developed Tests (LDTs). Gonzalez & Gail H.

Clinic 59

Clinic Management Medical IT 59

FDA Law

NOVEMBER 1, 2023

Lenz, Principal Medical Device Regulation Expert & Sophia R. Gibbs — For more than three decades, FDA has claimed that the Federal Food, Drug & Cosmetic (FD&C Act) gives the agency legal authority to regulate laboratory developed tests (LDTs) as medical devices (see our prior post here ). Gaulkin & Jeffrey N.

Manufacturing 81

Manufacturing Hospital Healthcare Medical 81

FDA Law

DECEMBER 12, 2022

This form lists important risks, including those known or reported to be associated with the use of the LASIK laser devices based on information from clinical trials, scientific literature, and reports from patients who have undergone LASIK. After reviewing the information. Regulatory Analysis.

Manufacturing 52

Manufacturing Provider Patients Medical 52

Today's Hospitalist

JUNE 7, 2025

Because many medications can cause weight gain, doctors should consider more weight-neutral alternatives. Medical societies and hospitals are weighing in on periprocedural concerns in patients taking GLP-1s who need procedures or surgeries. Key takeaways: Hospitalists will increasingly have to manage inpatients taking GLP-1s.

Hospital 66

Hospital Management Diabetes Patients 66

Permanente Medicine

APRIL 29, 2025

million men and women aged 50 to 75 examined the outcomes of a Kaiser Permanente Northern California initiative begun in 2006 to increase colorectal cancer screening rates. Levin, MD , a Kaiser Permanente Division of Research scientist and gastroenterologist with The Permanente Medical Group. The study of 1.1

Screening 52

Screening Checkup Integrated Care Electronics 52